Meluzio Michael Vincent

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 7
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Cue Biopharma, Inc.VP, Prin. Accounting OfficerOption exercisenothing paid13,647 sharesAug 17, 2026Cue Biopharma, Inc.VP, Prin. Accounting Officernothing paidExercise · Aug 17Option exercise13,647Aug 17, 2026
Cue Biopharma, Inc.VP, Prin. Accounting OfficerOpen-market sell$933 sharesAug 17, 2026Cue Biopharma, Inc.VP, Prin. Accounting Officer$93Sell · Aug 17Open-market sell3Aug 17, 2026
Cue Biopharma, Inc.VP, Prin. Accounting OfficerOpen-market sell$124,6174,106 sharesAug 17, 2026Cue Biopharma, Inc.VP, Prin. Accounting Officer$124,617Sell · Aug 17Open-market sell4,106Aug 17, 2026
Cue Biopharma, Inc.VP, Prin. Accounting OfficerOpen-market sell$44,6131,519 sharesAug 17, 2026Cue Biopharma, Inc.VP, Prin. Accounting Officer$44,613Sell · Aug 17Open-market sell1,519Aug 17, 2026
Cue Biopharma, Inc.VP, Prin. Accounting OfficerOption exercisenothing paid13,647 sharesAug 17, 2026Cue Biopharma, Inc.VP, Prin. Accounting Officernothing paidExercise · Aug 17Option exercise13,647Aug 17, 2026